drugset / Trial / NCT02616354
Preliminary Research On Two-step Dosing Of Imipenem/Cilastatin
RandomizedParallel-groupSingle-blindTreatment
Summary
Explore Imipenem/Cilastatin two-step dosing compared to 2 hours infusion in patients with severe whether can obtain better results of the pharmacokinetic/pharmacodynamic, for clinical rational use of antimicrobial agents, and provide theoretical support for optimizing dosage regimen.
Timeline
- Start
- 2015-01
- Primary completion
- 2015-11
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | IMIPENEM ANHYDROUS | Small molecule | 0.5 g | Intravenous |
| Comparator | IMIPENEM ANHYDROUS | Small molecule | 1 g | Intravenous |